After presenting comparable docking results last year—and using them to prospectively identify drug candidates on difficult targets—Deep Origin welcomes Isomorphic Labs to the frontier SOUTH SAN ...
Alphabet-backed start-up Isomorphic Labs has added another name to the roster of pharma companies tapping into its AI-based drug discovery engine. Johnson & Johnson's Janssen Biotech unit is the ...
The unveiling of the Isomorphic Labs Drug Design Engine (IsoDDE) represents a fundamental shift from merely predicting the shape of biological life to actively engineering its functions. While ...
Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left ...
SOUTH SAN FRANCISCO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Deep Origin, the computational drug discovery company replacing guesswork with prediction in small molecule drug development, today ...
Demis Hassabis is the co-founder and CEO of Google DeepMind, an AI research laboratory responsible for development of the Gemini large language model and AlphaFold, a system that revolutionized the ...
2025 was a challenging year for the UK biotech sector, but it ended the year with signs of "renewed confidence and broadening investor appetite." That is the conclusion of the annual assessment of the ...
Google AI CEO Demis Hassabis has cautioned against overstating the significance of AI systems like Gemini and ChatGPT solving international Maths Olympiad problems. Speaking at the India AI Impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results